Clene (CLNN) Total Current Liabilities (2019 - 2026)
Clene (CLNN) posted Total Current Liabilities of $4.9 million for Q2 2026, down 54.97% on a QoQ basis from $10.8 million in Q4 2025, and down 35.94% year-over-year from $7.6 million in Q2 2025.
Analysis
Clene (CLNN) Total Current Liabilities (2019 - 2026) Analysis & Trends
Clene has reported Total Current Liabilities for 8 years, with the latest figure at $4.9 million in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 35.94% year-over-year to $4.9 million in Q2 2026; TTM through Jun 2026 was $4.9 million, a 35.94% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, up 4.71% from the prior year.
- Total Current Liabilities was $4.9 million for Q2 2026 at Clene, down from $10.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $28.1 million in Q2 2024, with the low at $4.9 million in Q2 2026.
- Average Total Current Liabilities over 5 years is $13.4 million, with a median of $10.8 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 389.43% in 2024, then plunged 73.02% in 2025.
- Over 5 years, Total Current Liabilities stood at $13.9 million in 2022, then surged by 82.8% to $25.3 million in 2023, then slumped by 59.37% to $10.3 million in 2024, then gained by 4.71% to $10.8 million in 2025, then sank by 54.97% to $4.9 million in 2026.
- The last three Total Current Liabilities figures came in at $4.9 million (Q2 2026), $10.8 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 32.65 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 37.11 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 354.06 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.31 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 607.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 4.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Dec 31, 2025 | 10.78 Mn |
| Sep 30, 2025 | 8.31 Mn |
| Jun 30, 2025 | 7.57 Mn |
| Mar 31, 2025 | 10.76 Mn |
| Dec 31, 2024 | 10.29 Mn |
| Sep 30, 2024 | 23.83 Mn |
| Jun 30, 2024 | 28.07 Mn |
| Mar 31, 2024 | 26.19 Mn |
| Dec 31, 2023 | 25.33 Mn |
| Sep 30, 2023 | 15.27 Mn |
| Jun 30, 2023 | 5.74 Mn |
| Mar 31, 2023 | 16.88 Mn |
| Dec 31, 2022 | 13.86 Mn |
| Sep 30, 2022 | 6.15 Mn |
| Jun 30, 2022 | 7.66 Mn |
| Mar 31, 2022 | 5.47 Mn |
| Dec 31, 2021 | 6.03 Mn |
| Sep 30, 2021 | 4.83 Mn |
| Jun 30, 2021 | 4.52 Mn |